lovastatin has been researched along with Proteinuria in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 16 (84.21) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Fijter, JW; Dekker, FW; Dekkers, OM; Esmeijer, K; Hoogeveen, EK | 1 |
| Bahner, U; Heidland, A; Paczek, L; Schaefer, L; Schaefer, RM; Teschner, M | 1 |
| Davis, P; Exner, M; Kerjaschki, D; Neale, TJ; Ojha, PP; Poczewski, H; Rüger, B; Witztum, JL | 1 |
| Keane, WF | 1 |
| Correia, AM; Miguel, MJ; Nogueira, AC; Pinto, JR; Prata, MM; Rodrigues, MC; Vicente, O | 1 |
| Han, DC; Hwang, SD; Jin, SY; Lee, HB; Lee, SK | 1 |
| Fujishima, M; Nanishi, F; Okuda, S; Onoyama, K; Washio, M | 1 |
| Harris, KP; Hattersley, JM; Moorhead, JF; Ramaswamy, C; Thomas, ME; Varghese, Z; Walls, J; Wheeler, DC; Williams, JD | 1 |
| Alsina, J; Andrés, E; Castelao, AM; Castiñeiras, MJ; Galcerán, JM; Gilvernet, S; González, MT; Griñó, JM; Roca, M; Serón, D | 1 |
| Parving, HH | 1 |
| Kuiper, JJ | 1 |
| Breiteneder, S; Hörl, WH; Schmaldienst, S; Winkler, S | 1 |
| Kaysen, GA; Neverov, NI; Tareyeva, IE | 1 |
| Drukker, A; Eddy, AA | 1 |
| Breiteneder-Geleff, S; Haas, M; Holzer, H; Hörl, WH; Kerjaschki, D; Kramar, R; Mayer, G; Neuweiler, J; Neyer, U; Ratschek, M; Regele, HM; Schneider, B; Wirnsberger, G | 1 |
| Chan, PC; Cheng, IK; Robinson, JD; Tsang, MT; Yeung, HW; Yeung, WC | 1 |
| La Belle, P; Mantel, G | 1 |
| Delanghe, J; Deslypere, JP; Vermeulen, A | 1 |
| Bennett, WM; Golper, TA; Illingworth, DR; Morris, CD | 1 |
2 review(s) available for lovastatin and Proteinuria
| Article | Year |
|---|---|
Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis.
Topics: Atorvastatin; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Lovastatin; Network Meta-Analysis; Pravastatin; Proteinuria; Rosuvastatin Calcium; Simvastatin; Treatment Outcome | 2019 |
Lipids and the kidney.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Blood Pressure; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lovastatin; Male; Proteinuria | 1994 |
7 trial(s) available for lovastatin and Proteinuria
| Article | Year |
|---|---|
Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hyperlipidemias; Lipoproteins; Long-Term Care; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Patient Acceptance of Health Care; Prospective Studies; Proteinuria; Triglycerides | 1994 |
Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Double-Blind Method; Female; Humans; Hypercholesterolemia; Inulin; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Placebos; Proteinuria; Simvastatin; Triglycerides | 1993 |
HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
Topics: Adult; Anticholesteremic Agents; Apolipoproteins; Body Mass Index; Body Weight; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunosuppression Therapy; Kidney Transplantation; Lipids; Lipoproteins; Lovastatin; Male; Postoperative Complications; Proteinuria; Simvastatin; Triglycerides | 1993 |
Effect of lipid-lowering therapy on the progression of renal disease in nondiabetic nephrotic patients.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Cholesterol; Chronic Disease; Creatinine; Diet, Fat-Restricted; Disease Progression; Female; Glomerulonephritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lipoproteins; Lovastatin; Male; Middle Aged; Proteinuria | 1997 |
Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria.
Topics: Adult; Aged; Drug Tolerance; Female; Glomerulonephritis; Humans; Hyperlipidemias; Hypertriglyceridemia; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Rhabdomyolysis | 1992 |
Simvastatin and proteinuria.
Topics: Anticholesteremic Agents; Drug Administration Schedule; Drug Evaluation; Humans; Lovastatin; Proteinuria; Simvastatin | 1991 |
Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria.
Topics: Adrenal Cortex Hormones; Adult; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Random Allocation | 1989 |
10 other study(ies) available for lovastatin and Proteinuria
| Article | Year |
|---|---|
Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome.
Topics: Albuminuria; Animals; Doxorubicin; Endopeptidases; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Kidney Glomerulus; Lovastatin; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Inbred Lew | 1994 |
Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.
Topics: Aldehydes; Animals; Anticholesteremic Agents; Antigen-Antibody Complex; Basement Membrane; Cholesterol; Collagen; Disease Models, Animal; Epithelial Cells; Glomerulonephritis; Kidney Glomerulus; Lipid Peroxidation; Lovastatin; Lysine; Male; Malondialdehyde; Probucol; Proteinuria; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Simvastatin | 1994 |
Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Cholesterol; Enalapril; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Lovastatin; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Systole; Triglycerides | 1993 |
Effects of anti-hyperlipidaemic agent or dietary protein restriction on progressive renal deterioration in adriamycin-induced nephropathy in rats.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Cholesterol; Creatinine; Dietary Proteins; Doxorubicin; Glomerulosclerosis, Focal Segmental; Lovastatin; Male; Models, Biological; Proteinuria; Rats; Rats, Inbred Lew; Triglycerides | 1993 |
Cholesterol-lowering therapy may retard the progression of diabetic nephropathy.
Topics: Anticholesteremic Agents; Controlled Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Follow-Up Studies; Glomerular Filtration Rate; Humans; Lovastatin; Proteinuria; Research Design | 1996 |
Effects of weight reduction and angiotensin-converting enzyme inhibition on IgA nephropathy-associated proteinuria.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cholesterol; Diet, Reducing; Female; Glomerulonephritis, IGA; Hematuria; Humans; Lisinopril; Lovastatin; Middle Aged; Obesity; Proteinuria; Weight Loss | 1996 |
Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cyclosporine; Enalapril; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl CoA Reductases; IgA Vasculitis; Immunosuppressive Agents; Lovastatin; Male; Methylprednisolone; Middle Aged; Nephrotic Syndrome; Plasmapheresis; Prednisone; Proteinuria | 1997 |
Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol; Collagen; Female; Fibronectins; Fibrosis; Kidney; Lipid Peroxides; Lipoproteins, LDL; Liver; Lovastatin; Macrophages; Microscopy, Fluorescence; Nephrotic Syndrome; Organ Size; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta; Treatment Failure; Vitamin E | 1998 |
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
Topics: Adult; Anticholesteremic Agents; Antioxidants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glomerulonephritis, Membranous; Humans; Kidney Function Tests; Lipid Peroxidation; Lovastatin; Male; Middle Aged; Probucol; Prospective Studies; Proteinuria; Treatment Outcome | 2002 |
Proteinuria as complication of simvastatin treatment.
Topics: Albuminuria; Anticholesteremic Agents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Proteinuria; Simvastatin; Transferrin | 1990 |